We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toDebunking-Decentralized-Trials-Sharing-Breakthroughs-and-Deal-Breakers

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Debunking Decentralized Trials: Sharing Breakthroughs and Deal Breakers

    Session Chair(s)
      Jane E. Myles, MS

      Jane E. Myles, MS

      • Head, Operational Intelligence and Innovation
      • Genentech, A Member of the Roche Group, United States
    In this forum, a panel of experts will share their experience on the breakthroughs -what really works, and the deal breakers -what’s not working yet or was harder than expected. Our aim is to debunk the decentralized trial hype and share lessons learned. The forum will include perspectives from a sponsor, a decentralized trial vendor, a 'site' and if possible, a patient who has participated in a decentralized trial.
    Learning Objective : Discuss key learnings about what's working and not working in decentralized trials; Discuss individual experiences on design and implementation of decentralized trials; Describe the patient and site perspective on participation in decentralized trials.
      Leonard  Sacks, MD


      Leonard Sacks, MD

      • Associate Director for Clinical Methodology, Office of Medical Policy, CDER
      • FDA, United States
      Komathi  Stem, MS


      Komathi Stem, MS

      • Founder and Chief Executive Officer
      • monARC Bionetworks , United States
      Gerrit  Hamre, MA


      Gerrit Hamre, MA

      • Clinical Project Manager
      • Clinical Trials Transformation Initiative (CTTI), United States